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Background: Children with overweight/obesity and congenital heart disease (CHD) are 
at increased cardiovascular risk. A lifestyle intervention may help reduce these risks. 
We sought to determine the feasibility of a smartphone-based lifestyle intervention to 
improve cardiovascular health outcomes in children with overweight/obesity and CHD.
Methods: We examined the effect of bi-weekly nutrition and fitness counseling delivered 
via smartphone over 12 months. Thirty-four youth, previously diagnosed with CHD and 
with overweight or obesity, participated in the intervention. They were divided into two 
groups depending on whether the heart disease required surgical correction (operated, 
n = 19) or not (non-operated, n = 15). Anthropometry, body composition cardiorespi-
ratory exercise capacity, and cardio-metabolic risk factors were assessed at baseline, 
6 months, and 12 months.
results: Statistically significant decreases in waist circumference (WC), body mass 
index z-score, WC z-score, and waist to height ratio z-score were observed at 6 and 
12 months in the operated group. A significant linear increase in lean body mass was 
observed in both groups. The study also had a high retention rate and a low attrition rate.
conclusion: The observed changes in anthropometry were positive with significant 
improvement to some cardiovascular and metabolic risk indicators. However, this was 
only observed in the operated group suggesting that other factors, such as perception 
of condition and self-efficacy, may influence lifestyle behaviors. The results from this pilot 
study clearly demonstrate the feasibility to perform a larger controlled study on remote 
lifestyle intervention in children with congenital heart defects and overweight or obesity.
Keywords: smartphone, congenital heart disease, remote counseling, obesity, children, lifestyle intervention
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inTrODUcTiOn
Currently, about one-third of children in Canada and the United 
States are overweight or obese, and our group and others have 
found that the prevalence of overweight and obesity between 
children with congenital heart disease (CHD) and healthy chil-
dren do not differ significantly (1–3). The numerous cardiovas-
cular risks, and physical and psychosocial health consequences 
of childhood obesity are well reviewed (4, 5). Although evidence 
is now emerging, children with overweight or obesity and CHD 
appear more likely to exhibit additional cardiovascular risk 
factors, such as higher systolic blood pressure and lower high 
density lipoproteins (HDL), compared to children of normal 
weight (1, 6).
Unhealthy eating habits, sedentary behavior, and reduced 
physical activity can increase the risk of obesity and cardiovas-
cular disease (7). Children with CHD are less physically active 
(8) and have a lower health-related quality of life than their peers 
(9). Although a structured lifestyle intervention for children 
and youth with overweight or obesity and CHD has never been 
completed, it has the potential to diminish cardiovascular health 
risks by improving nutrition, physical fitness, body composi-
tion, and related health outcomes (10). However, conventional 
pediatric lifestyle intervention programs struggle with barriers 
to their success, such as high attrition rates and therapeutic non-
compliance (11).
Smartphones may address some of the inherent challenges 
of structured lifestyle interventions by eliminating geographi-
cal barriers, maintaining the home environment and appealing 
to a more technologically savvy generation. Overall, mobile 
devices offer promising results for improving weight loss and 
health behaviors, but their application has not been explored 
in a pediatric population with overweight or obesity and 
CHD (12–14). In addition, weight-loss interventions using 
remote counseling have been shown to be as effective as in-
person support for weight loss in an adult population with 
obesity (15).
The objective of the “Smart Heart” Pilot Study (registered as 
NCT02980393 at http://www.ClinicalTrials.gov) was to examine 
the cardiovascular health impact of a 12-month, structured 
lifestyle intervention program for children and adolescents with 
overweight or obesity and CHD through the use of smartphones. 
It was hypothesized that participants would demonstrate favora-
ble changes in anthropometric, body composition, exercise 
capacity, and metabolic parameters associated with cardiovascu-
lar health. We also sought to determine if self-efficacy resulting 
from the perceived severity of CHD influences the outcomes of 
the intervention.
MaTerials anD MeThODs
study Design
Eligible candidates were selected during routine visits and through 
chart review by cardiologists at the London Health Sciences 
Centre (LHSC) (London, ON, Canada). Consenting individuals 
underwent a physical assessment and a review of medications and 
comorbidities during the first stage of measurements. All patients 
were recruited from within our catchment area of Southwestern 
Ontario, Canada.
Two groups of patients were recruited for this study, those 
who had undergone corrective surgery for CHD (“operated”) and 
those with minor heart defects that do not require surgical cor-
rection (“non-operated”). All subjects had overweight or obesity. 
Both groups received the identical intervention.
Candidates were excluded from the study if they: had severe 
residual heart disease, were at risk for a worsening cardiac 
condition, were unable to participate due to mental or physi-
cal disabilities, had imposed exercise restrictions, were taking 
confounding medications, had comorbidities affecting weight or 
metabolic conditions, or were involved in any concurrent lifestyle 
intervention. This study was approved by the Western University 
Health Science Research Ethics Board (REB#18843) and the 
Lawson Health Research Institute (R-12-266). All subjects gave 
written informed consent in accordance with the Declaration 
of Helsinki. All children and adolescents gave written informed 
consent to participate in this study. For those under 16 years of 
age, we obtained written informed consent from their parents/
guardians.
The primary outcome measures were anthropometry, body 
composition, and cardiorespiratory exercise capacity. The 
secondary metrics included biochemical markers associated 
with cardiovascular health and risk. Outcomes were assessed at 
baseline and 6 and 12 months following baseline at the Children’s 
Hospital, LHSC and Western University, Ontario, Canada. The 
Smart Heart Pilot Study protocol is outlined in Figure 1.
Primary  Outcome Measures
Anthropometry
Weight and height were measured to the nearest 0.1 kg and to 
the nearest 0.1 cm, respectively. Waist circumference (WC) was 
measured according to the NHANES III Body Measurements 
protocol (16). Briefly, WC was measured at least twice with a 
flexible tape to the nearest 0.1 cm at the tip of the iliac crest. An 
average was taken of the first two measures with internal varia-
tion of ≤1 cm. The z-scores were calculated using the following 
formula: z
X
M
LS
L
=




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
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, where X is the BMI, WC, or waist to 
height ratio (WHtR); L is lambda, M is mu, and S is sigma. Age 
and gender based values for L, M, and S were obtained from the 
growth charts provided by the CDC and Sharma et al. (17, 18).
Body Composition Measurements
Dual X-ray absorptiometry (iDXA; General Electric-Lunar 
iDXA, Ames Medical iDXA; Prodigy, enCORE 2007 software 
Abbreviations: CHD, congenital heart disease; iDXA, dual X-ray absorptiometry; 
BMI, body mass index; BMI-Z, body mass index z-score; WC, waist circumference; 
WC-Z, waist circumference z-score; WHtR, waist to height ratio; WHtR-Z, waist to 
height ratio z-score; FM, fat mass; BF, body fat; %BF, percent body fat; LBM, lean 
body mass; VO2max, maximal volume oxygen uptake; LDL, low density lipoproteins; 
HDL, high density lipoproteins; TG, triglycerides; HOMA-IR, homeostatic model 
assessment for insulin resistance.
FigUre 1 | Flow diagram of the Smart Heart Pilot Study procedure from baseline to 12-month measures. The Smart Heart Pilot Study included three assessments 
and spanned 12 months. Self-report, physical, metabolic, cardiovascular, and body composition outcome measures were collected for each participant at baseline 
and at 6- and 12-month follow-ups. Nutrition and fitness counseling was performed by smartphone once per week, with the nutrition and fitness counseling support 
alternating weeks (i.e., 25 counseling sessions for each, for a total of 50 sessions).
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version 11.40.004, Waukesha, WI, USA) was used to measure 
body fat (kg) and lean body mass (LBM) (kg). Lunar iDXA has 
been previously validated (19).
Cardiorespiratory Exercise Capacity
Tests were performed at the Pediatric Cardiopulmonary Research 
Laboratory, Children’s Hospital, LHSC, or at the Exercise and 
Health Psychology Lab, Western University, Ontario, Canada. 
Breath-by-breath data on the volume of oxygen uptake (VO2) 
(mL) and carbon dioxide production (mL) were collected during 
a maximal exercise graded treadmill test using a Cosmed Quark 
b2 indirect calorimetry metabolic system (Cosmed S.r.I, Rome, 
Italy). An electrocardiogram was used simultaneously to monitor 
heart rate and identify arrhythmias and ST changes. The goal was 
to determine peak VO2 based on a respiratory exchange ratio (R) 
≥1.05 (20).
secondary Outcome Measures
Participants fasted for ≥10  h and blood collected. The lipid 
profile [total cholesterol, triglycerides and high and low density 
lipoproteins (HDL, LDL)], fasting plasma glucose, hemoglobin 
A1C, and insulin levels were measured using standard pro-
tocols at the LHSC Core laboratory. The homeostatic model 
assessment—insulin resistance [homeostatic model assessment 
for insulin resistance (HOMA-IR)] was calculated using the fol-
lowing formula: HOMA FPG FPIIR =
∗( ∗ )0 144
22 5
.
.
; where FPG is 
fasting plasma glucose levels (mmol/L) and FPI is fasting plasma 
insulin levels (pmol/L).
lifestyle intervention
During the baseline visit, participants were provided a com-
plimentary smartphone. The lifestyle intervention involved 
alternating weekly phone calls with two health coaches: a 
registered dietitian and a fitness specialist. A total of 50 phone 
calls were delivered to each participant over the 12  months. 
Counseling sessions were ≤30 min. Counseling strategies were 
focused on education, behaviors, and family engagement and 
included regular evaluations. The primary counseling topics are 
outlined in Table 1. The counseling was tailored to the specific 
needs of each patient (e.g., lactose intolerance, sports nutrition, 
exercise modifications during injury recovery), and good sleep-
ing habits were emphasized.
statistical analyses
Means and SDs were calculated for all continuous variables. With 
the exception of z-scores, RM-ANCOVA was conducted for 
each outcome across the three time points (baseline, 6 months, 
and 12  months), while adjusting for age and sex. The z-scores 
(already adjusted for age and sex) for BMI (BMI-Z), WC (WC-
Z), and WHtR (WHtR-Z) were analyzed using RM-ANOVA. The 
analyses were performed independently on both the operated 
and non-operated groups. For outcomes significant at p < 0.05, 
Bonferroni post hoc comparisons examined pairwise differences 
between time points.
BMI z-scores were also calculated from clinic visits from 6 to 
42 months prior to the start of the study (Figure 2). This time 
frame was selected as it represented a long enough period prior 
to study start to observe any trends and maximized the avail-
ability of data for performing linear regression. A smoothed 
line of fit was determined for each group using locally weighted 
scatterplot smoothing (loess) and 70% of the data points with the 
Epanechnikov kernel. Linear regression was used to determine the 
pre-intervention body mass index z-score (BMI-Z) trajectory for 
each group using data up to, and including, the baseline.
TaBle 1 | Lifestyle counseling: the primary topics for nutrition and fitness.
nutrition program counseling topics
Education and strategies
•	 Canada’s Food Guide as a resource
•	 Planning balanced and healthier meals
•	 Approaches to grocery shopping
•	 Understanding nutrition labels
•	 Choosing healthier drinks over sugar-
sweetened drinks
•	 Increasing consumption of vegetables 
and fruit
•	 Strategies for eating outside of home
•	 Packing lunches
•	 Family meals
•	 Eating breakfast
Behaviors
•	 Eating in moderation
•	 Slower eating
•	 Focused eating
•	 Division of responsibility in feeding
•	 Snacking
•	 Hunger and satiety cues
•	 Emotional eating
Family engagement
Phase 1. Months 0–6: Bi-weekly 
resources
Phase 2. Months 6–12: Monthly  
nutrition challenges
Evaluation
Every 3 months (food records or diet 
recall)
Eating habits questionnaires (4 in total) 
(phase 2. Months 6–12 only)
Fitness program counseling topics
Education and strategies
•	 Canada’s Physical Activity and 
Sedentary Behavior Guidelines as 
a resource
•	 Benefits of physical activity and 
impacts of sedentary behavior
•	 Interconnection of lifestyle behaviors 
(sleep, activity)
•	 Supports and environments (home, 
school, etc.)
•	 Intensity levels
Behaviors
Phase 1. Months 0–6
•	 Planning and goal-setting
•	 Self-monitoring
•	 Overcoming barriers
•	 Incorporating activity into regular 
daily routine (e.g., taking the stairs)
Phase 2. Months 6–12
•	 Challenging current physical activity 
levels and diversity of movement 
choices
•	 Sustaining motivation levels and 
incorporation of rewards
Evaluation:
Bi-weekly (physical activity recall)
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All statistical analyses were performed using SPSS v.23 or v.24 
(IBM Corporation, Armonk, NY, USA).
resUlTs
Patient recruitment spanned May 2012 to October 2015. Thirty-
four patients (15 females, 19 males) with overweight or obesity 
(21), between 7 and 17 years of age (mean 14.3 ± 2.8 years) at 
the time of screening, were recruited. Of these, n = 19 had CHD 
that required corrective surgery (operated group) while n = 15 
had CHD that did not require corrective surgery (non-operated 
group). Patient assessments spanned January 2013 to October 
2016. One participant from each group did not complete the 
6-month follow-up assessment and were excluded from all 
repeated measures statistical analyses.
The operated group consisted of patients diagnosed with 
one or more of the following: aortic stenosis, atrial septal defect 
(type II), atrio-ventricular septal defect, coarctation of the aorta, 
hemitruncus, hypoplastic left heart syndrome, patent ductus 
arteriosus, pulmonic stenosis, transposition of the great arteries, 
or tetralogy of Fallot. While the non-operated group consisted 
of patients diagnosed with one or more of the following: aortic 
root dilation, aortic stenosis, aortic valve regurgitation, ascend-
ing aortic dilatation, atrial septal defect (type II), bicuspid 
aortic valve, coronary sinus atresia, coronary sinus draining into 
innominate vein, mitral valve prolapse, mitral valve regurgita-
tion, patent ductus arteriosus, pulmonic stenosis, subaortic ridge, 
systolic ejection murmur, or ventricular septal defect.
The fitness and nutrition counselors allocated 30 min for each 
session: 15–20 min for counseling and 10–15 min for charting. 
Thus, the primary cost of applying the intervention was approxi-
mately a combined 25 professional working hours for the weekly 
remote smartphone counseling per participant over 12 months.
There was no significant difference between HDL, LDL, 
TG, fasting plasma glucose, hemoglobin A1C, insulin levels, 
HOMA-IR, and maximal volume oxygen uptake at baseline, 
6 months, or 12 months for both groups.
Tables  2 and 3 summarize the key outcome measures at 
baseline, 6  months, and 12  months. There was a significant 
linear decrease in WC, BMI-Z, waist circumference z-score 
(WC-Z), and WHtR-Z over 12  months in the operated group. 
Post hoc comparisons showed significant differences between 
baseline and both the 6- and 12-month time points for BMI-Z, 
WC-Z, WHtR-Z, and LBM. There was only a significant differ-
ence between baseline and the 6-month time point for WC. By 
the end of the study, BMI-Z decreased by 0.12 (95% CI 0.002 
to 0.28), WC-Z decreased by 0.24 (95% CI 0.05 to 0.43), and 
WHtR-Z decreased by 0.26 (95% CI 0.02 to 0.50). WC decreased 
by 2.61 cm (0.12 to 5.09) after 6 months, and by 2.25 cm (−1.58 
to 6.09) after 12 months, but the decrease at study end was not 
significant relative to baseline (Table  2). For the non-operated 
group a small, but significant, increase in the BMI of 1.50 (95% 
CI −0.13 to 2.87) between baseline and 12 months was observed 
(Table 3). A significant linear increase in LBM over the 12-month 
period, with an increase of 2.87  kg (95% CI 1.47 to 4.26) and 
2.32 kg (95% CI 0.40 to 4.23) at study end, was observed for both 
the operated and non-operated groups, respectively.
Examining the trend in BMI-Z prior to the start of the study 
until study completion revealed interesting trends (Figure 2). For 
the operated group (solid black line), the BMI-Z increased over 
time until the start of the intervention at which the BMI-Z showed 
a decline until the study end. However, for the non-operated 
group (solid gray line), the BMI-Z showed a similar increase 
over time prior to the start of the intervention, but leveled off 
after, and reverted back to an increasing trajectory. Of note, the 
BMI-Z was approximately 0.5 higher throughout in the operated 
group relative to the non-operated group. This is attributed to 
the group composition, as 74% of the operated, and 27% of the 
non-operated, group had obesity. A pre-intervention trajectory 
was determined for each group using linear regression on data 
spanning 42  months prior to, and including, baseline (dashed 
lines). Comparing the overall line of fit to the trajectories one can 
readily observe the impact of the intervention. The decrease in 
BMI-Z in the operated group is apparent, but also of note is the 
disruption to an expected increase in BMI-Z in the non-operated 
group (Figure 2).
DiscUssiOn
Our pilot and feasibility study on a smartphone-based lifestyle 
intervention successfully demonstrated improved anthropome-
tric and body composition measures in children with overweight 
FigUre 2 | Trends in body mass index z-score (BMI-Z) score. The BMI-Z was plotted over time (months) relative to the study start date (month 0) for each of the 34 
participants divided into the operated congenital heart disease (CHD) (n = 19) and non-operated CHD (n = 15) groups. The BMI-Z was determined for each of the 
34 study participants, when possible, from 42 months to 6 months prior to the study start date (month 0) and during the intervention at 0, 6, and 12 months. Loess 
was used to generate a smoothed line of fit for the operated (solid black line) and non-operated (solid gray line) groups. Linear regression was performed using data 
from months −42 to 0 to determine a trajectory for the BMI-Z (dashed lines). For the operated group, n = 14 of 19 had from 2 to 4 BMI-Z measurements prior to the 
study start; while for the non-operated group, n = 11 of 15 had 1 to 3 BMI-Z measurements prior to the study start. All 34 participants had BMI-Z measurements 
over the course of the intervention (i.e., at 0, 6, and 12 months) with the exception of one participant in each of the two groups that missed the 6-month follow-up. 
The study start point (0 months) is indicated by a vertical line.
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or obesity and operated CHD. While we did not observe the same 
outcomes in the non-operated group, we did observe a disruption 
in the predicted linear increase in BMI-Z likely attributed to the 
intervention. To the best of our knowledge, this is the first study to 
implement this type of intervention in a pediatric CHD popula-
tion. Furthermore, our study had superior participant retention 
and attrition rates compared to similar lifestyle intervention 
studies (22). We believe this to be attributed to the use of smart-
phones in the study, which enabled us to effectively engage with 
the participants, despite geographic or scheduling limitations. 
Overall, the results from this study effectively demonstrated the 
feasibility of the current protocol, and the implemented remote 
lifestyle intervention strategy, to move forward with a larger 
controlled study.
In a systematic review of 38 eligible studies conducted 
between 1975 and 2010, Ho et al. concluded that pooled pedi-
atric obesity lifestyle interventions reduced BMI-Z by 0.10 (95% 
CI 0.02–0.18) (22). A similar change was seen in the operated 
study group, suggesting the intervention was as successful as 
other interventions at decreasing and sustaining BMI-Z for the 
6- and 12-month periods. Few lifestyle intervention studies on 
children and adolescents with overweight or obesity employed 
WC, WHtR, or their corresponding z-scores as part of their 
outcome measures; for studies that did so, the results were 
inconsistent (22).
For the operated group, changes in BMI-Z, WC, WC-Z, and 
WHtR-Z occurred within the first 6  months of the program 
and remained relatively unchanged at 12 months. This was not 
unexpected, as Franz et al. reported that the largest loss in weight 
occurred within the first 6  months and was maintained after 
12 months in a review of 80 weight-loss intervention studies in 
adults (23). Moreover, Franz et  al. stated that although weight 
loss leveled off after the initial reduction, stopping the interven-
tions altogether would likely have led to weight gain (23). Since 
there were no increases in anthropometric measures after the 
6-month point in our study, this suggests that participants in the 
operated group were likely still engaged with the intervention 
while the non-operated group was not. This also indicates that 
TaBle 3 | Comparison of anthropometric, body composition, cardiorespiratory and cardio-metabolic risk factor outcome measures for the non-operated group.
Measurements Baseline,  
mean (sD)
6 months,  
mean (sD)
12 months, 
mean (sD)
p-Value Mean difference  
B to 6 (95% ci)
Mean difference  
B to 12 (95% ci)
Heart Ratec (bpm) 102.7 (10.5) 96.8 (12.4) 102.2 (14.4) 0.910 −5.91 (−16.4 to 4.6) −0.55 (−7.7 to 6.6)
Systolic BPa (mmHg) 119.5 (8.2) 119.6 (10.3) 122.2 (9.9) 0.412 0.08 (−8.6 to 8.8) 2.7 (−5.9 to 11.3)
Diastolic BPa (mmHg) 72.9 (8.4) 70.1 (6.3) 69.5 (6.6) 0.335 −2.8 (−11.7 to 6.2) −3.3 (−11.7 to 5.1)
BMI (kg/m2) 27.74 (4.42) 27.95 (4.24) 29.24 (4.81) 0.046* 0.20 (−0.65 to 1.06) 1.50 (−0.13 to 2.87)* 
BMI-Z 1.63 (0.49) 1.61 (0.52) 1.70 (0.55) 0.182 −0.026 (−0.16 to 0.11) 0.07 (−0.10 to 0.24)
WCb (cm) 98.0 (13.5) 99.5 (8.5) 103.2 (11.8) 0.760 1.6 (−3.7 to 6.8) 5.3 (−0.3 to 10.3)
WC-Zb 1.56 (0.49) 1.62 (0.34) 1.67 (0.41) 0.312 0.07 (−0.14 to 0.26) 0.12 (−0.14 to 0.37)
WHtRb 0.60 (0.07) 0.60 (0.05) 0.62 (0.07) 0.892 0.003 (−0.025 to 0.032) 0.022 (−0.012 to 0.055)
WHtR-Zb 1.47 (0.52) 1.55 (0.33) 1.62 (0.44) 0.287 0.08 (−0.15 to 0.31) 0.15 (−0.18 to 0.48)
Fat Mass (kg) 29.8 (9.5) 30.1 (9.1) 32.7 (11.3) 0.076 0.23 (−2.93 to 3.39) 2.93 (−1.46 to 7.13)
Body Fat (%) 39.5 (5.5) 39.2 (5.7) 40.3 (6.5) 0.579 −0.29 (−2.7 to 21) 0.76 (−2.26 to 379)
Lean Body Mass (kg) 44.3 (86) 45.0 (84) 46.6 (8.5) 0.000* 0.73 (−1.12 to 2.59) 2.32 (0.40 to 4.23)*
Lean Body Mass (%) 59.3 (5.35) 58.8 (5.78) 57.8 (6.34) 0.220 −0.51 (−2.41 to 1.39) −1.48 (−4.03 to 1.07)
p-value from RM-ANOVA or RM-ANCOVA.
95% CI, 95% confidence interval for mean difference between baseline (B) and 6 months (6) or 12 months (12); BP, blood pressure; BMI, body mass index; WC, waist 
circumference; WHtR, waist to height ratio; -Z, z-score.
n = 14, unless otherwise indicated.
an = 13.
bn = 12.
cn = 11.
*Post hoc test p ≤ 0.05.
TaBle 2 | Comparison of anthropometric, body composition, cardiorespiratory and cardio-metabolic risk factor outcome measures for the operated group.
Measurements Baseline,  
mean (sD)
6 months,  
mean (sD)
12 months,  
mean (sD)
p-Value Mean difference B  
to 6 (95% ci)
Mean difference B  
to 12 (95% ci)
Heart rateb (bpm) 97.7 (10.1) 89.2 (16.9) 98.2 (12.6) 0.873 −8.4 (−19.2 to 2.4) 0.5 (7.7 to 8.7)
Systolic BPa (mmHg) 114.0 (11.7) 114.8 (6.8) 116.4 (8.7) 0.225 0.8 (−5.4 to 7.0) 2.4 (−5.0 to 9.8)
Diastolic BPa (mmHg) 62.9 (8.4) 68.3 (2.3) 69.9 (5.4) 0.404  5.3 (−1.0 to 11.6) 7.0 (−0.2 to 14.2)
BMI (kg/m2) 30.17 (4.95) 29.71 (4.47) 29.79 (4.31) 0.207 −0.47 (−1.50 to 0.57) −0.38 (−1.79 to 1.02)
BMI-Z 2.06 (0.374) 1.95 (0.398) 1.92 (0.395) 0.012* −0.10 (−0.21 to −0.002)* −0.14 (−0.28 to −0.002)*
WCa (cm) 95.91 (11.75) 93.30 (11.77) 93.65 (10.63) 0.028* −2.61 (−5.09 to −0.12)* −2.25 (−6.09 to 1.58)
WC-Za 1.72 (0.393) 1.53 (0.546) 1.48 (0.551) 0.001* −0.19 (−0.33 to −0.06)* −0.24 (−0.43 to −0.05)*
WHtR 0.584 (0.076) 0.562 (0.084) 0.566 (0.096) 0.994 −0.022 (−0.039 to 0.004) −0.024 (−0.049 to 0.002)
WHtR-Z 1.50 (0.574) 1.27 (0.719) 1.24 (0.718) 0.003* −0.23 (−0.38 to −0.08)* −0.26 (−0.50 to −0.02)*
Fat mass (kg) 33.28 (10.22) 32.02 (9.53) 32.27 (9.53) 0.177 −1.26 (−3.25 to 0.73) −1.01 (−4.34 to 2.32)
Body fat (%) 41.08 (7.30) 38.64 (8.09) 38.24 (8.04) 0.297 −2.44 (−5.86 to 0.97) −2.84 (−6.20 to 0.51)
Lean body mass (kg) 47.97 (13.92) 49.23 (14.18) 50.84 (13.94) 0.009* 1.26 (0.06 to 2.47)* 2.87 (1.47 to 4.26)**
Lean body mass (%) 57.13 (6.71) 58.44 (7.80) 59.01 (7.65) 0.731 1.31 (−0.81 to 2.69) 1.88 (0.30 to 4.06)
p-value from RM-ANOVA or RM-ANCOVA.
95% CI, 95% confidence interval for mean difference between baseline (B) and 6 months (6) or 12 months (12); BP, blood pressure; BMI, body mass index; WC, waist 
circumference; WHtR, waist to height ratio; -Z, z-score.
n = 18, unless otherwise indicated.
an = 16.
bn = 17.
*Post hoc test p ≤ 0.05.
**Post hoc test p ≤ 0.001.
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the intervention may not have been rigorous enough, and posi-
tive changes may have continued with a more aggressive diet and 
exercise plan.
The significant findings in the operated group were not 
entirely replicated in the non-operated group, although they both 
received the identical intervention. We believe this may be due 
self-efficacy and how the parents/patients perceive the seriousness 
of their condition in relation to lifestyle (24–26). For example, 
the operated group may have had a much better understanding 
of their disease and the impact of overweight and obesity on their 
health and were more engaged as a result. It is also possible the 
operated group had been more reserved in their physical activity 
due to the perceived seriousness of their condition and increased 
efforts during the intervention as it was regularly monitored by 
medical professionals. However, it is important to note that most 
of the participants in the operated group were obese, whereas 
the non-operated participants were predominantly overweight, 
which may have enabled more rapid positive changes from the 
intervention. We believe further studies are warranted to test 
these hypotheses.
A meta-analysis by Stoner et al. found that structured exercise 
interventions slightly increased LBM by 1.6 kg (95% CI 0.5–2.6) 
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while also attenuating percent body fat (%BF) by 3.1% (95% CI 
2.2–4.1) in overweight and obese adolescents (27). While we 
observed a significant linear increase in age and sex adjusted 
LBM by 2.9  kg (95% CI 1.47–4.26) from baseline, there was 
no apparent increase in the percent LBM. This suggests that 
LBM and total body mass increased linearly together over the 
12-month period. However, there appeared to be decreases in 
the fat mass and %BF from baseline to 6 and 12 months in our 
study, but it did not reach statistical significance due to the large 
variance (Table 2). Thus, the increased LBM is likely the result 
of normal childhood growth. This is not surprising given that 
our intervention did not include a regimented physical exercise 
component and structured resistance or weight training compo-
nents. Also, another possibility was the sample size in our study 
was not representative enough to adjust for the strong association 
between LBM and pubertal growth.
We did not observe any significant changes in any of the 
measured cardio-metabolic outcomes in our study as reported 
with other interventions (22). However, as reported in a review 
by Ho et al., there were no clear associations between the extent 
of weight loss or body fat reduction and improvements in cardio-
metabolic outcomes (22). Thus, the changes observed in these 
studies may independently result from the lifestyle intervention 
itself, through increased physical activity and an improved diet, 
as opposed to weight loss directly. While we did observe positive 
anthropometric changes in our study, the intervention may not 
have been adequate enough to drive improvements in cardio-
metabolic outcomes.
A significant increase in peak VO2 has been reported in several 
studies on physical exercise training programs in children and 
young adults with CHD (28, 29). Similar age and sex adjusted 
results were not observed in our study, which was likely a conse-
quence of lacking a regimented physical exercise component and 
participant engagement.
The differences observed between this study and those 
reported in the reviews by Ho et al. (22), Tikkanen et al. (28), 
and Duppen et al. (29) may be explained by limitations of the 
intervention components. For instance, Ho et al. (22) noted the 
features of effective interventions were: family involvement, 
dietary intervention (typically a structured restrictive diet), 
and structured exercise training (22). Unfortunately, the Smart 
Heart Pilot Study did not strive for significant family involve-
ment, which may have had an impact on the study, as engag-
ing family members can enhance the effectiveness of weight 
management (30, 31). Also, dietary and fitness components 
were designed to be realistic, sustainable, and empowering for 
young people living in an uncontrolled environment; as such 
we did not prescribe regimented diet and exercise plans. Since 
the physical activity component of lifestyle interventions is 
specifically associated with improvements in body composition, 
one must also consider the differing degrees of physical activ-
ity participation (frequency, duration, and intensity) achieved 
by study participants as a potential explanation. Furthermore, 
reliance on participant self-report regarding their engagement 
in physical activity was an additional challenge to increasing 
physical activity levels in this remote intervention as self-report 
can be influenced by social desirability and recall bias, and may 
also lead to overestimations of both the quantity and intensity 
of effort (32).
Ultimately, one of the primary reasons we did not observe 
significant differences in many of the cardio-metabolic and body 
composition outcome measures was likely a consequence of 
the small sample size used in the study. We were hopeful the 
intervention-driven changes would be large enough to detect, 
but unfortunately the power of the study was too low to detect 
these small differences. This was also compounded by the large 
degree of variation in the metrics used given the age range of 
the study population and the large rapid changes associated 
with puberty. This can be particularly true for changes in height, 
body fat distribution, and insulin levels over a 12-month period. 
Furthermore, our primary interest was to determine if the 
proposed remote-counseling intervention would be feasible in a 
pediatric CHD population, which our results support. However, 
not including a control non-CHD population has introduced 
some limitations to the study interpretation regarding the 
presence of CHD and its influence on patient engagement and 
measured outcomes. Ideally, a randomized control trial would 
prove to be most beneficial and believe our current protocol is 
applicable to a larger randomized control study.
Retention is also an important indicator of program feasibility. 
A retention rate of 100% (i.e., no drop-outs) and an attrition rate 
of 2% (i.e., 2 of 102 clinic visits missed) are atypical for a lifestyle 
intervention program of this duration and nature. Dhaliwal et al. 
documented a median attrition rate of 37% (range 4–83%) from 
23 published pediatric lifestyle interventions (33). Logistical bar-
riers were one of the most commonly cited reasons for dropout. 
The Smart Heart Pilot Study reduced the need for families to 
travel during the intervention by providing remote counseling 
via smartphones. The majority of participants would have been 
required to travel ~50 to 200  km to the hospital. Smartphone 
counseling removed the burdens of traveling to the hospital, 
missed school and work, as well as the costs of public transit, 
petrol, and parking. It is also important to note that enrolled 
subjects may have been more amenable to lifestyle changes simply 
due to their interest in participating in the study, which could lead 
to bias in the results.
There is no research evaluating lifestyle interventions for 
children with overweight or obesity and CHD using smart-
phones. This is the first study to explore this novel approach to 
implementing a lifestyle intervention in this high risk popula-
tion. The Smart Heart Pilot Study proved to be cost-effective and 
demonstrated a superior participant retention rate compared to 
similar pediatric lifestyle interventions not using smartphones 
for remote counseling. Preliminary evidence demonstrates 
that the Smart Heart Pilot Study had a positive effect on LBM, 
BMI-Z, WC, WC-Z, and WHtR-Z, but this may have been 
dependent on self-efficacy and the perception of the underly-
ing heart condition. Despite some study limitations, the results 
suggest that a larger study would be highly feasible and likely 
prove more successful with improvements to the intervention 
protocol. Continued research should elucidate whether the 
aforementioned enhancements to the delivery of pediatric 
obesity lifestyle interventions demonstrate further improved 
cardiovascular health outcomes.
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eThics sTaTeMenT
This study was carried out in accordance with the recommenda-
tions of the Western University, Lawson Health Research Institute 
and London Health Sciences Centre research guidelines with 
written informed consent from all subjects. All subjects gave 
written informed consent in accordance with the Declaration 
of Helsinki. All children and adolescents gave written informed 
consent to participate in this study. For those under 16 years of 
age, we obtained written informed consent from their parents/
guardians. The protocol was approved by the Western University 
Health Science Research Ethics Board (REB#18843) and the 
Lawson Health Research Institute (R-12-266).
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